HB Fuller (FUL) Guides Sales for 2H'12
- Global stocks slide as yen, euro gains question policy potency
- IMS Health (IMS), Quintiles (Q) Enter Merger Agreement; Carries Enterprise Value of $23B
- After-Hours Stock Movers 05/02: (FN) (BECN) (THC) (YELP) Higher; (ONDK) (CYH) (BETR) (SRPT) Lower (more...)
- No respite for Japan as yen soars to 18-month high
- Steven Cohen: hedge fund crowding caused major February loss
Speaking on the company's Q2 conference call, an exec from HB Fuller (NYSE: FUL) is expecting sales of $1.05-$1.1 billion during the second half of this year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clorox (CLX) Tops Q3 EPS by 10c; Lifts Outlook
- Tessera Technologies (TSRA) Tops Q1 EPS by 3c
- WellCare Health Plans (WCG) Tops Q1 EPS Views; Boosts FY16 Outlook
Create E-mail Alert Related CategoriesConference Calls, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!